Puma Biotechnology

+$0.04 (+0.41%) Today
+$0.52 (+5.37%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell PBYI and other stocks, options, and ETFs commission-free!

About PBYI

Puma Biotechnology Inc Common Stock, also called Puma Biotechnology, is a biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer.

CEO
Alan H. Auerbach
Employees
267
Headquarters
Los Angeles, California
Founded
2010

PBYI Key Statistics

Market Cap
411.37M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
261.58K
High Today
$9.93
Low Today
$9.40
Open Price
$9.54
Volume
360.17K
52 Week High
$14.14
52 Week Low
$7.48

PBYI News

BenzingaMay 5

Puma Biotechnology's Earnings Outlook

On Thursday, May 06, Puma Biotechnology (NASDAQ:PBYI) will report its last quarter's earnings. Here is Benzinga's preview of the company's release. Net Income,

PBYI Earnings

-$0.73
-$0.30
$0.12
$0.55
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
$0.09 per share
Actual
$0.55 per share
Replay Earnings Call

You May Also Like

GAB-J
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure